18F-labelled folates

Details for Australian Patent Application No. 2008237930 (hide)

Owner Merck Eprova AG

Inventors Ross, Tobias Ludwig; Groehn, Viola; Ametamey, Simon Mensah; Lam, Phoebe; Moser, Rudolf

Agent Davies Collison Cave

Pub. Number AU-A-2008237930

PCT Pub. Number WO2008/125613

Priority 07105976.0 11.04.07 EP

Filing date 11 April 2008

Wipo publication date 23 October 2008

International Classifications

C07B 59/00 (2006.01) Introduction of isotopes of elements into organic compounds

A61B 5/00 (2006.01) Measuring for diagnostic purposes

C07D 475/04 (2006.01) Heterocyclic compounds containing pteridine ring systems

Event Publications

29 October 2009 PCT application entered the National Phase

  PCT publication WO2008/125613 Priority application(s): WO2008/125613

8 December 2011 Alteration of Name

  The name of the applicant has been altered to Merck & Cie

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008237932-18 F-labelled folates

2008237929-Method of determining a chemotherapeutic regime and survival expectancy for non small cell lung cancer based on EGFR/CSF-1/CA IX expression